Therefore, the decline of CD80 positive cells in the present study may point to the activation of T-cell mediated anti-tumor immune response and a difference between the function of CD86 and CD80 in CCH seems likely. This evidence concerns the gene CD80 and columnar cell hyperplasia of the breast.